Innogenetics NV - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Innogenetics NV Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Innogenetics NV. The Group's principal activities are to provide diagnostic and therapeutic products using biotechnological research. The Diagnostics business focuses on infectious diseases, genetic testing, and neurodegeneration of many common diseases like HIV, Syphilis, Mycobacteria, Alzheimer's disease, HLA Class I and II etc. The Therapeutics division develops vaccines for infectious diseases for which current treatment options are limited. Their products include vaccines for Hepatitis B, Hepatitis C, Pulmonary Edema and other hard-to-heal wounds. The Group has operations in the United States, Germany, Spain, Italy, France, Brazil and the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report